List view / Grid view
21 September 2018 | By Iqra Farooq (Drug Target Review)
Scientists from Spain have identified the specific roles of chemical tags in mammalian development and cancer in controlling genes...
19 September 2018 | By ELRIG
ELRIG’s (European Laboratory Research & Innovation Group) Drug Discovery meeting, will take place at ExCeL, London, UK, located in the heart of the city, from 9 -10 October 2018...
18 September 2018 | By Drug Target Review
Researchers in the U.S. have identified that lymphatic vessels in the brain appear to play a crucial role in the development and progression of multiple sclerosis (MS), providing focus for new treatment research.
17 September 2018 | By BMG Labtech GmbH
Due to the crucial role of G protein-coupled receptors (GPCRs) in mediating cellular responses to external stimuli, these receptors have been and will remain a prime focus for medical research and the pharmaceutical industry for many years to come. Their importance is especially highlighted by the statistic that 30-50% of…
14 September 2018 | By Drug Target Review
Researchers from Texas University have used data from men with COPD to ascertain that testosterone replacement therapy could be beneficial...
13 September 2018 | By Drug Target Review
Researchers have combined an open source software programme and commercially available hardware to image neuron activity at high resolution...
12 September 2018 | By Drug Target Review
Researchers have condensed methods for identifying cancer gene mutations in cells into a single process, to aid understanding of tumours and improve treatment outcomes.
12 September 2018 | By BMG Labtech GmbH
This webinar shines a spotlight on cell-based and biochemical high-throughput screening in 1536 well plates. Supported by BMG LABTECH, the webinar will take place on 30 October at 4:00pm (GMT).
11 September 2018 | By Drug Target Review
Individualised therapies that target the specific genetic features of tumours have the potential to transform cancer diagnosis, treatment and care. However, several challenges remain before these approaches can be widely used in the clinic.
10 September 2018 | By Sheraz Gul
This webinar, supported by Bio-Techne, will trace the journey of medical treatments from small molecule to cellular therapies. It will take place on 16 October 2018 at 3.00pm (BST).
10 September 2018 | By Yasmina Noubia Abdiche (Carterra)
Explore the full kinetic and epitope diversity of large antibody libraries with high throughput Array SPR (Surface Plasmon Resonance).
7 September 2018 | By Derek Davis - The Francis Crick Institute, Dr Rachael Walker - Babraham Institute
For many years, screening assays have been based on high-content imaging systems. However, recent advances in the field of flow cytometry have meant that flow-based assays are now more prevalent. The power of flow cytometry to utilise multiple lasers, multiple fluorochromes and multiplexed assays has meant that assays are not…
7 September 2018 | By Drug Target Review
Researchers have developed a see-through, dual-layered, mesh EEG device which is capable of measuring the electrical activity of individual neurons...
7 September 2018 | By Thomas D. Duensing (IntelliCyt)
Biologics are the fastest growing class of therapeutics in the biopharmaceutical industry. A key driver for this growth is success with anti-cancer immunotherapeutics such as checkpoint modulation, adoptive cell therapy and bispecific T-cell engagers. While these approaches use different tactics to attack tumours, they often employ monoclonal antibodies to target…
7 September 2018 | By Drug Target Review
Scientists have shared a new method that aims to accelerate the discovery of chemical compounds that inhibit a particular enzyme implicated in several cancers.
Follow: